Results showed that the expression of NKG2D was significantly reduced in T2DM patients (Figure 3A), while no differences in NKp46 and CD69 expression levels were observed among groups (Figure 3B, C). The gene discussed is CD69; the disease is type 2 diabetes mellitus.